Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

243.94
Delayed Data
As of Sep 23
 +0.51 / +0.21%
Today’s Change
195.50
Today|||52-Week Range
322.68
-21.94%
Year-to-Date
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
8:01am / MotleyFool.com - Paid Partner Content
Wallace Weitz's Largest 2nd-Quarter Trades
Sep 22 / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
The Good, the Bad and the Ugly in Today's Market
Sep 22 / TheStreet.com - Paid Partner Content
ETFs in Focus on the Nasdaq Rally
Sep 23 / Zacks.com - Paid Partner Content
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Allergan/Adamas Launch New Dosage Strengths of Namzaric
Sep 23 / Zacks.com - Paid Partner Content
Is Galectin The Next Takeover Target for the Biotech World?
Sep 22 / Zacks.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
Jim Cramer's Top Takeaways: Flex, Walt Disney, Allergan
Sep 22 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close243.43
Today’s open242.49
Day’s range242.49 - 246.50
Volume2,686,485
Average volume (3 months)3,161,651
Market cap$96.6B
Dividend yield--
Data as of 4:00pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.95%
Earnings growth (next 5 years)+13.53%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.22-0.57%
BMYBristol-Myers Squibb+0.06+0.11%
LLYEli Lilly and Co-0.13-0.16%
NVONovo Nordisk-0.69-1.51%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$3.65
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs